Targeting Dsg3 has been shown to be both necessary and sufficient to cause disease using in vitro and murine in vivo models of PV (Amagai et al., 1994, 1996; Ishii et al., 2005; Koch et al., 1997). The gene discussed is DSG3; the disease is acquired polycythemia vera.